Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 21Unknown 4Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Lymphoid 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2Prevention of Colorectal Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Selenium × Clear all
NCT00553124 2014-01-10

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
3,400 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00553345 2014-01-10

Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
515 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT01211561 2010-09-29

Colon Cancer Prevention Using Selenium

University of Illinois at Chicago

Phase EARLY_PHASE1 Unknown
50 enrolled
Gastrointestinal

Prevention of Colorectal Cancer

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown
45 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡